Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity
Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Giuseppe Palma(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Irma Bisceglia(Azienda Ospedaliera San Camillo-Forlanini), Christian Cadeddu Dessalvi(University of Cagliari), Carlo Maurea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gerardo Ferrara(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano Berretta(University of Messina), Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Celeste Fonderico(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alfredo Mauriello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandro Inno(Ospedale Sacro Cuore Don Calabria), Matteo Barbato(University of Milan), Anna Chiara Maratea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesca Bruzzese(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Annabella Di Mauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Laura Canale(Ospedale Versilia), Antonio Luciano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 9
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
|Critical Reviews in Oncology/Hematology|2019|164
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
|Frontiers in Physiology|2018|154
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
|Antioxidants and Redox Signaling|2017|122
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116